e-learning
resources
Barcelona 2013
Wednesday, 11.09.2013
New molecular and cell biology mechanisms
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Expression of angiogenic regulators in alpha-1 antitrypsin deficient COPD
M. Olfert, M. Malek, T. Eagan, P. Wagner (Morgantown, Detroit, La Jolla, United States Of America; Bergen, Norway)
Source:
Annual Congress 2013 –New molecular and cell biology mechanisms
Session:
New molecular and cell biology mechanisms
Session type:
Oral Presentation
Number:
5007
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Olfert, M. Malek, T. Eagan, P. Wagner (Morgantown, Detroit, La Jolla, United States Of America; Bergen, Norway). LATE-BREAKING ABSTRACT: Expression of angiogenic regulators in alpha-1 antitrypsin deficient COPD. Eur Respir J 2013; 42: Suppl. 57, 5007
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
LATE-BREAKING ABSTRACT: Smoking reduces klotho expression
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Differences in training response between patients with alpha-1 antitrypsin deficiency and COPD patients
Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases
Year: 2015
LATE-BREAKING ABSTRACT: alpha-1 antitrypsin activates protein phosphatase 2A (PP2A) to counter lung inflammatory responses
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
Features of skeletal muscle dysfunction in COPD patients with obesity
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Evaluation of anti-aging klotho protein in COPD rehabilitation
Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases
Year: 2016
LATE-BREAKING ABSTRACT: Corticosteroid responsiveness in COPD
Source: International Congress 2016 – Novel strategies on COPD and asthma management
Year: 2016
Serum transforming growth factor –β1 (TGF-β1) in asthmatics: Association between disease control, severity and duration
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Circulating levels of IGF-I and IGFBP-3 in patients with COPD
Source: International Congress 2015 – COPD: notable points
Year: 2015
LATE-BREAKING ABSTRACT: Cardiovascular and skeletal muscle manifestations in COPD: The ERICA study
Source: International Congress 2016 – Novel approaches for pulmonary rehabilitation in chronic lung diseases
Year: 2016
LATE-BREAKING ABSTRACT: Defect of HDAC7 causes impaired VEGF expression in response to hypoxia in COPD
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013
LATE-BREAKING ABSTRACT: Role of mir23a and PGC-1 alpha in Pulmonary Hypertension.
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Skeletal muscle atrophy caused by acute pulmonary inflammation is dependent on a glycogen synthase kinase-3beta - glucocorticoid receptor signaling axis
Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Year: 2015
Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
Klotho expression is reduced in COPD
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013
Gender differences in COPD patients: Skeletal muscle function and structure
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
Oxidative stress in TGF-β1-mediated fibrosis in Z alpha-1 antitrypsin cells
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
Reduced expression of peroxisome proliferator-activated receptors (PPARs) in skeletal muscle of patients with COPD
Source: Annual Congress 2006 - Respiratory muscles
Year: 2006
LATE-BREAKING ABSTRACT: The influence of four weeks of beta2-adrenoceptor activation with oral terbutaline on body composition and skeletal muscle contractile properties in active men
Source: International Congress 2014 – Pathophysiological mechanisms at different scales
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept